From kellyfrevel@... Tue Jan 13 10:49:01 2009
Return-Path: <kellyfrevel@...>
X-Sender: kellyfrevel@...
X-Apparently-To: experimentalandunconventional@yahoogroups.com
X-Received: (qmail 11414 invoked from network); 13 Jan 2009 18:48:58 -0000
X-Received: from unknown (66.218.67.95)
by m56.grp.scd.yahoo.com with QMQP; 13 Jan 2009 18:48:58 -0000
X-Received: from unknown (HELO n17c.bullet.sp1.yahoo.com) (69.147.64.126)
by mta16.grp.scd.yahoo.com with SMTP; 13 Jan 2009 18:48:58 -0000
X-Received: from [69.147.65.174] by n17.bullet.sp1.yahoo.com with NNFMP; 13 Jan 2009 18:48:58 -0000
X-Received: from [66.218.66.80] by t12.bullet.mail.sp1.yahoo.com with NNFMP; 13 Jan 2009 18:48:58 -0000
Date: Tue, 13 Jan 2009 18:48:57 -0000
To: experimentalandunconventional@yahoogroups.com
Message-ID: <gkinmp+85q1@eGroups.com>
User-Agent: eGroups-EW/0.82
MIME-Version: 1.0
Content-Type: text/plain; charset="ISO-8859-1"
Content-Transfer-Encoding: quoted-printable
X-Mailer: Yahoo Groups Message Poster
X-Yahoo-Newman-Property: groups-compose
X-Originating-IP: 69.147.64.126
X-eGroups-Msg-Info: 1:12:0:0:0
X-Yahoo-Post-IP: 66.93.119.161
From: "kellyfrevel" <kellyfrevel@...>
Subject: New Treatment Stage II colon cancer - OncoVAX
X-Yahoo-Group-Post: member; u=380378834; y=CzZVq-LxbkDAeGxN4z1pn7bDwAdtu19GmG9i5LVmUHxh0Ke_4D0
X-Yahoo-Profile: kellyfrevel
While I know screening can be the biggest prevention of this disease,
I want to make everyone aware of a new vaccine that is on the verge of
replacing chemotherapy. The name of the vaccine is OncoVAX
(<http://vaccinogeninc.com/oncovax.html>). It is from a company called
Vaccinogen (<http://www.vaccinogeninc.com/index.htm>).
This vaccine is available to anyone that has been diagnosed with Stage
II colon cancer and HASN'T had surgery. Currently this vaccine is only
available commercially in Europe but arrangements can be made for the
patient to have surgery in the United States, which would possibly be
covered by insurance, but the OncoVAX treatment itself will be out of
pocket. Following surgery, a patient-specific vaccine is made from the
patient's resected tumor that when injected back into the patient
decreases the chance of the cancer returning from 1 in 3 to 1 in 10.
These are odds everyone should be aware of.
While I know screening can be the biggest prevention of this disease, I want to make everyone aware of a new vaccine that is on the verge of replacing...